Author
Listed:
- Ylenia Perone
(Imperial College London)
- Aaron J. Farrugia
(Institute of Cancer Research)
- Alba Rodríguez-Meira
(Imperial College London
University of Oxford)
- Balázs Győrffy
(Hungarian Academy of Sciences
Semmelweis University)
- Charlotte Ion
(Imperial College London)
- Andrea Uggetti
(European Institute of Oncology)
- Antonios Chronopoulos
(Imperial College London)
- Pasquale Marrazzo
(University of Bologna)
- Monica Faronato
(Imperial College London)
- Sami Shousha
(Charing Cross Hospital NHS Trust)
- Claire Davies
(Imperial College London)
- Jennifer H. Steel
(Imperial College London)
- Naina Patel
(Imperial College London)
- Armando Rio Hernandez
(Imperial College London)
- Charles Coombes
(Imperial College London)
- Giancarlo Pruneri
(Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine)
- Adrian Lim
(Imperial College London)
- Fernando Calvo
(Institute of Cancer Research
Instituto de Biomedicina y Biotecnologia de Cantabria)
- Luca Magnani
(Imperial College London)
Abstract
Approximately 30% of ERα breast cancer patients relapse with metastatic disease following adjuvant endocrine therapies. The connection between acquisition of drug resistance and invasive potential is poorly understood. In this study, we demonstrate that the type II keratin topological associating domain undergoes epigenetic reprogramming in aromatase inhibitors (AI)-resistant cells, leading to Keratin-80 (KRT80) upregulation. KRT80 expression is driven by de novo enhancer activation by sterol regulatory element-binding protein 1 (SREBP1). KRT80 upregulation directly promotes cytoskeletal rearrangements at the leading edge, increased focal adhesion and cellular stiffening, collectively promoting cancer cell invasion. Shearwave elasticity imaging performed on prospectively recruited patients confirms KRT80 levels correlate with stiffer tumors. Immunohistochemistry showed increased KRT80-positive cells at relapse and, using several clinical endpoints, KRT80 expression associates with poor survival. Collectively, our data uncover an unpredicted and potentially targetable direct link between epigenetic and cytoskeletal reprogramming promoting cell invasion in response to chronic AI treatment.
Suggested Citation
Ylenia Perone & Aaron J. Farrugia & Alba Rodríguez-Meira & Balázs Győrffy & Charlotte Ion & Andrea Uggetti & Antonios Chronopoulos & Pasquale Marrazzo & Monica Faronato & Sami Shousha & Claire Davies , 2019.
"SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer,"
Nature Communications, Nature, vol. 10(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09676-y
DOI: 10.1038/s41467-019-09676-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09676-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.